Treatment of Acute Liver Failure in Pigs Reduces Hepatocyte Function in a Bioartificial Liver Support System

No abstract is available for this paper.

• Publication year

  2002

• Venue

  International Journal of Artificial Organs

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/039139880202501011PMID 12456038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Semipermeable hollow fiber membranes in hepatocyte bioreactors: a prerequisite for a successful bioartificial liver?

  2008cited by this paper
• The bioartificial liver: state-of-the-art.

  2003cited by this paper
• A Bioartificial Liver--State of the Art

  2002cited by this paper
• ASSESSMENT OF THE AMC-BIOARTIFICIAL LIVER IN THE ANHEPATIC PIG1

  2002cited by this paper
• UvA-DARE ( Digital Academic Repository ) In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates

  2001cited by this paper
• Advances in bioartificial liver devices

  2001cited by this paper
• Cytoprotective influence of ZVAD-fmk and glycine on gel-entrapped rat hepatocytes in a bioartificial liver.

  2000cited by this paper
• Developments in bioartificial liver research: concepts, performance, and applications

  2000cited by this paper
• Effects of Anticoagulants on Porcine Hepatocytes in Vitro: Implications in the Porcine Hepatocyte-Based Bioartificial Liver

  1999cited by this paper
• Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability.

  1999cited by this paper
• Bioreactors for Hybrid Liver Support: Historical Aspects and Novel Designs

  1999cited by this paper
• Significantly Improved Survival Time in Pigs with Complete Liver Ischemia Treated with a Novel Bioartificial Liver

  1999influential reference
• Apoptosis by gel-entrapped hepatocytes in a bioartificial liver.

  1999cited by this paper
• Does the Extend of the Culture Time of Primary Hepatocytes in a Bioreactor Affect the Treatment Efficacy of a Bioartificial Liver?

  1998influential reference
• Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver.

  1997cited by this paper
• Treatment of acetaminophen-induced fulminant hepatic failure with a bioartificial liver.

  1997cited by this paper
• Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

  1997cited by this paper
• Functional stability of porcine hepatocyte spheroids in various culture systems under 100% porcine and human plasma conditions.

  1996cited by this paper
• Use of Bioartificial and Artificial Liver Support Devices

  1996cited by this paper
• Consideration of Potential Immunological Problems in the Application of Xenogenic Hybrid Liver Support

  1996cited by this paper
• Clinical Experience with a Porcine Hepatocyte-Based Liver Support System

  1996cited by this paper
• Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure

  1996cited by this paper
• The Effect of Catabolite Concentration on the Viability and Functions of Isolated Rat Hepatocytes

  1996cited by this paper
• In vitro function of porcine hepatocyte spheroids in 100% human plasma.

  1996cited by this paper
• Immunologic considerations in the use of cultured porcine hepatocytes as a hybrid artificial liver. Anti-porcine hepatocyte human serum.

  1993cited by this paper
• The use of porcine hepatocytes for biotransformation studies of veterinary drugs.

  1989cited by this paper
• Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure.

  1982influential reference
• Preparation of isolated rat liver cells.

  1976cited by this paper

• Resveralogues protect HepG2 cells against cellular senescence induced by hepatotoxic metabolites.

  2024cites this paper
• Therapeutic Opportunities Presented by Modulation of Cellular Senescence.

  2023cites this paper
• Optimized performance of the integrated hepatic cell-loaded cryogel-based bioreactor with intermittent perfusion of acute liver failure plasma.

  2018cites this paper
• Artificial Liver Bioreactor Design

  2016cites this paper
• Effects of acute‐liver‐failure‐plasma exposure on hepatic functionality of HepaRG‐AMC‐Bioartificial Liver

  2013cites this paper
• Perfusion flow rate substantially contributes to the performance of the HepaRG‐AMC‐bioartificial liver

  2012cites this paper
• The Effect of Rat Acute-Liver-Failure Plasma on HepaRG Cells

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) Human liver cell lines for the AMC-bioartificial liver

  2012cites this paper
• Human liver cell lines for the AMC-bioartificial liver

  2012cites this paper
• Human liver cell lines for the AMC-bioartificial liver

  2012cites this paper
• Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-Bioartificial Liver

  2012cites this paper
• Towards application of a human liver cell line for use in the AMC bioartificial liver

  2011cites this paper
• Activation, isolation, identification and culture of hepatic stem cells from porcine liver tissues

  2011cites this paper
• Protective effects of ACLF sera on metabolic functions and proliferation of hepatocytes co-cultured with bone marrow MSCs in vitro.

  2011cites this paper
• Towards application of a human liver cell line for use in the AMC bioartificial liver

  2011cites this paper
• Bio-artificial liver support system : an evaluation of models used in demonstrating or improving metabolic and clinical efficacy

  2010cites this paper
• A Model of Ischemic Isolated Acute Liver Failure in Pigs: Standardizing Monitoring and Treatment

  2010cites this paper
• Use of a Rotary Bioartificial Liver in the Differentiation of Human Liver Stem Cells

  2009cites this paper
• Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma.

  2009cites this paper
• Effect of human patient plasma ex vivo treatment on gene expression and progenitor cell activation of primary human liver cells in multi‐compartment 3D perfusion bioreactors for extra‐corporeal liver support

  2009cites this paper
• GUIDELINES FOR CLINICAL PRACTICE Future of bioartificial liver support

  2009cites this paper
• Future of bioartificial liver support.

  2009cites this paper
• Introduction of a Novel Prototype Bioartificial Liver Support System Utilizing Small Human Hepatocytes in Rotary Culture

  2008cites this paper
• Enhanced oxygen availability improves liver-specific functions of the AMC bioartificial liver.

  2008cites this paper
• Time-Related Analysis of Metabolic Liver Functions, Cellular Morphology, and Gene Expression of Hepatocytes Cultured in the Bioartificial Liver of the Academic Medical Center in Amsterdam (AMC-BAL)

  2007cites this paper
• Towards application of a human liver cell line for use in the AMC bioartificial liver

  2007cites this paper
• Subnormothermic preservation maintains viability and function in a porcine hepatocyte culture model simulating bioreactor transport.

  2006cites this paper
• Subnormothermic Preservation Maintains Viability and Function in a Porcine Hepatocyte Culture Model Simulating Bioreactor Transport

  2006cites this paper
• The Amsterdam bioartificial liver

  2005cites this paper
• Mild Hypothermic Preservation for Transport Purposes of the AMC Bioartificial Liver Charged with Porcine Hepatocytes

  2005cites this paper
• Liver Support Therapy: An Overview of the AMC-Bioartificial Liver Research

  2005cites this paper
• Assessment and Improvement of Liver Specific Function of the AMC-Bioartificial Liver

  2005cites this paper
• Hemodynamic parameters in a surgical devascularization model of fulminant hepatic failure in the minipig.

  2005cites this paper
• Bioartificial liver systems: current status and future perspective.

  2005cites this paper
• Clinical Application of Bioartificial Liver Support Systems

  2004cites this paper
• Influence of Serum from Rats with Fulminant Hepatic Failure on Hepatocytes in a Bioartificial Liver System

  2004cites this paper
• Cell choice for bioartificial livers.

  2003cites this paper